Molina Healthcare (MOH)

• Market cap: $17.5B
• 1 day: -0.69%
• 5 days: -0.03%
• 1 month: 9.79%
• 3 months: 7.27%
• 6 months: -10.01%
• Year to date: 9.62%
• 1 year: -24.95%
• 5 years: 161.35%
• 10 years: 383.45%
• Sector: Financials
• Industry: Hospital & Medical Service Plans

About: Molina Healthcare Inc offers healthcare plans focused on Medicaid-related solutions for low-income families and individuals. Its health plans are operated by a network of subsidiaries, each of which is licensed as a health maintenance organization (HMO). It has four segments: Medicaid, Medicare, Marketplace and Others. The Medicaid, Medicare, and Marketplace segments represent the government-funded or sponsored programs under which it offers managed healthcare services. The Other segment, which is insignificant to its consolidated results of operations, includes long-term services and supports consultative services in Wisconsin. It generates majority revenue from Medicaid segment.

Employees: 18,000

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

39% more first-time investments, than exits

New positions opened: 99 | Existing positions closed: 71

3% more funds holding

Funds holding: 605 [Q3] → 621 (+16) [Q4]

3% less repeat investments, than reductions

Existing positions increased: 224 | Existing positions reduced: 232

4.19% less ownership

Funds ownership: 94.83% [Q3] → 90.64% (-4.19%) [Q4]

19% less capital invested

Capital invested by funds: $19.1B [Q3] → $15.5B (-$3.67B) [Q4]

23% less call options, than puts

Call options by funds: $67.1M | Put options by funds: $87.3M

43% less funds holding in top 10

Funds holding in top 10: 7 [Q3] → 4 (-3) [Q4]

Research analyst outlook

6 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $305 3% downside
• Avg. target: $346 10% upside
• High target: $376 19% upside

6 analyst ratings

• positive: 3 50%
• neutral: 3 50%
• negative: 0 0%

Wells Fargo Stephen Baxter 30% 1-year accuracy 12 / 40 met price target	18% upside $372	Overweight Upgraded	5 Mar 2025
Mizuho Ann Hynes 67% 1-year accuracy 10 / 15 met price target	19% upside $376	Outperform Maintained	3 Mar 2025
Truist Securities David Macdonald 55% 1-year accuracy 52 / 94 met price target	8% upside $340	Buy Maintained	19 Feb 2025
Barclays Andrew Mok 29% 1-year accuracy 17 / 58 met price target	8% upside $339	Equal-Weight Maintained	7 Feb 2025
UBS Kevin Caliendo 57% 1-year accuracy 8 / 14 met price target	3% downside $305	Neutral Maintained	7 Feb 2025